Demand for safe packaging to combat illicit drug market rackets on the rise
Pharma manufacturers are feeling encouraged to explore new possibilities.
Future Market Insights offers key insights on the global anti-counterfeit pharmaceutical packaging market in a new report titled, "Anti-counterfeit Pharmaceutical Packaging Market: Global Industry Analysis and Opportunity Assessment, 2016-2026". The global anti-counterfeit pharmaceutical packaging market is projected to register a robust CAGR of 12.1% during the forecast period 2016-2026. The report provides in-depth information on the global anti-counterfeit pharmaceutical packaging market pertaining to the market trends, competitive landscape, market dynamics, and market estimation and forecast for the projected ten-year period.
Demand for safe packaging to combat illicit drug market rackets spread across the globe is increasing. The present market is plagued by forged pharmaceutical formulas. The soaring market size of counterfeit drugs is creating a parallel economy in the global market. The emerging threat has a rippling effect on all the stakeholders as well as on the consumers. This dark underbelly of the pharmaceutical industry is crippling the growth of the market. The increasing dominance of counterfeit drugs has compelled pharma manufacturers to set up a safety ring to guard them against this threat. Anti-counterfeiting packaging is one of the measures that pharma majors are relying on. They are also using conventional solutions such as integrating authentication overt features with covert elements, forensics, and track & trace elements. These measures have fetched fruitful results for pharmaceutical companies and tier II pharma organisations in the recent past. Mushrooming popularity of anti-counterfeit pharmaceutical packaging technology is affecting the global demand for anti-counterfeit pharmaceutical packaging.
The efforts of WHO and FDA to ensure safe-conduct practices across the pharmaceutical industry value chain by integrating advanced anti-counterfeit packaging technology has encouraged pharma manufacturers to explore new possibilities. This, in turn, is creating value for suppliers of anti-counterfeit packaging technology to the pharmaceutical industry. The global anti-counterfeit pharmaceutical packaging market is responding with a positive growth rate, which is likely to continue during the forecast period.
Segmentation highlights
The global anti-counterfeit pharmaceutical packaging market is segmented on the basis of usage feature (convert features, divert features, forensic markers, tamper evidence and track & trace technologies [sterilization and identification system]) and technology (RFID [active tags, passive tags, semi-active tags], security inks and coatings, security printing and graphics, hologram, mass encoding [Barcode Application, Digital Mass Serialization, Digital Mass Encryption], others [Electromagnetic, surveillance technologies]).
Regional market projections
The report covers the global anti-counterfeit pharmaceutical packaging market across seven key regions namely - North America, Latin America, Western Europe, Eastern Europe, Japan, Asia Pacific Excl. Japan (APEJ), and the Middle East and Africa (MEA). On the basis of region, North America region is projected to remain dominant in the global anti-counterfeit pharmaceutical packaging market throughout the forecast period. Anti-counterfeit pharmaceutical packaging market in North America is expected to take a major leap within the forecast period given the active presence of major pharma companies, swelling exports and several biologics research hubs that are likely to expedite market growth.
Anti-counterfeit pharmaceutical packaging is expected to witness robust growth in the APAC market driven by increasing demand for anti-counterfeit measures in the region and the market is growing at the CAGR of 18.9 % over the forecast period. In MEA region the new wave of economic reforms is wooing foreign investors. Africa is an emerging economy that is influencing local as well as international players. The anti-counterfeit pharmaceutical market in Middle East & Africa is estimated to expand at a fast-paced CAGR of 11.5% by 2026 owing to the staggering growth in the economy of the region.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance